NRX-101 for Treatment of Moderate Bipolar Depression and Suicidal Ideation The MBD Study
Not yet recruiting
Phase of Trial: Phase II/III
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Cycloserine/lurasidone (Primary) ; Lurasidone
- Indications Bipolar depression
- Focus Registrational; Therapeutic Use
- Sponsors NeuroRX
- 29 Nov 2018 Planned initiation date changed from 1 Apr 2018 to 1 Jan 2019.
- 16 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Apr 2018.
- 12 Jan 2018 New trial record